According to Swedish Orphan Biovitrum's latest financial reports the company's current EPS (TTM) is 0,62 โฌ. In 2022 the company made an earnings per share (EPS) of 0,59 โฌ a decrease over its 2021 EPS that were of 0,88 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | 0,65 โฌ | 8.94% |
2022 | 0,59 โฌ | -32.67% |
2021 | 0,88 โฌ | -16.9% |
2020 | 1,06 โฌ | 2.54% |
2019 | 1,03 โฌ | 19.37% |
2018 | 0,87 โฌ | 98.42% |
2017 | 0,44 โฌ | 41.84% |
2016 | 0,31 โฌ | 1227.12% |
2015 | 0,02317 โฌ | -117.81% |
2014 | -0,13 โฌ | 184.25% |
2013 | -0,04578 โฌ | -12.81% |
2012 | -0,05251 โฌ | -433.93% |
2011 | 0,01572 โฌ | -126.14% |
2010 | -0,06014 โฌ | -258.4% |
2009 | 0,03797 โฌ |